6 results about "Total blood" patented technology

The utility model discloses a blood pad blood volume counting and counting device, a lifting belt of each blood pad is provided with an electronic tag, the blood pad blood volume counting and counting device comprises an electronic scale and a carrying disc, the electronic scale comprises a shell, a weighing table and a display table, and the weighing table is arranged on the top surface of the shell and located on the rear side of the shell; the display table is arranged on the top surface of the shell and is positioned on the front side of the shell; the carrying disc is suitable for being placed on the weighing table and is used for storing a used blood pad; the electronic scale further comprises a supporting table used for supporting the lifting belt of the blood pad, and the supporting table is provided with a tag reader used for reading the electronic tag. The display table is configured to be capable of displaying the total blood content of the blood pads and the number of the blood pads. According to the counting and counting device for the blood volume of the blood pad, the dual functions of counting the blood pad and measuring the blood volume can be automatically completed, and the efficiency and the accuracy of measuring the blood volume in the operation process are improved.

A method for collecting blood components using a medical system, the method comprising: receiving data associated with a subject by the medical system, the data associated with the subject including the subject's initial hematocrit value; determining the amount of subject-specific pure component to be collected by the medical system, the amount of subject-specific pure component to be collected by the medical system being determined using the subject's hematocrit value, the subject's total blood volume, and a target change in the hematocrit value; and performing a component collection process using the medical system to collect the determined amount of subject-specific pure component.

The invention discloses a pulsating flow blood injury assessment system and method for a double-loop nested low-pre-charge medical instrument, and belongs to the technical field of medical instruments. The system comprises a physiological pulsating pressure simulation loop and an instrument test blood carrying loop. The physiological pulsating pressure simulation loop is composed of a mechanical human body circulation simulation system and comprises a left ventricle, an aorta compliance cavity, a pipeline, a sensor and a power system. The instrument test blood carrying loop comprises a flexible blood bag, a blood carrying pipeline and a to-be-tested medical instrument. The two loops are nested and coupled through the flexible blood bag, and the flexible blood bag is immersed in water-glycerol liquid of the physiological pulsating pressure simulation loop to realize non-contact pressure transmission. The total blood pre-filling amount of the system is smaller than 500 mL, an SEBS blood bag and a heparinization coating are adopted, a non-contact sensor and an actuator are combined, and extra blood damage is remarkably reduced. According to the invention, low-pre-charge and high-biocompatibility pulsating flow blood injury accurate evaluation is realized, and the method is suitable for blood compatibility test of medical instruments such as a ventricular assist device and the like.

This disclosure provides Single cell Isotopomer Distributions and Energetics of Translation under Energetic Stress (SIDETES), a novel strategy to deconvolve metabolic heterogeneity in complex cellular environments, such as tumor and other tumor-resident cell populations, endocrine tissues, whole blood (Peripheral Blood Mononuclear Cells (PBMCs), or lymphoid organs. SIDETES can examine energetic dependence of a substrate, an inhibitor / activator, or a genetic change on rare cells in tumors, and obtain the network response for cells sorted by energy.

Apparatuses and methods for measuring total blood volume with ultrasound are disclosed. In one embodiment, a system for monitoring a blood volume of a patient includes an ultrasound transmitter configured for emitting an ultrasound toward a target blood vessel of the patient; and an ultrasound receiver configured for receiving the ultrasound reflected from the target blood vessel of the patient. The system also includes, a controller configured for: determining an expanded state of the blood vessel based on the ultrasound reflected from the target blood vessel; determining a collapsed stated of the blood vessel based on the ultrasound reflected from the target blood vessel; and determining the blood volume of the patient based on the ratio of the collapsed stated and the expanded stated of the blood vessel.

To provide a composition that can promote the production of IL-10 in intestinal epithelial cells. [Solution] A composition containing dead lactic acid bacteria belonging to the genus Lactiplantibacillus, which has an effect of promoting IL-10 production in intestinal epithelial cells, promotes the production of IL-10, an anti-inflammatory immune-related cytokine, in intestinal epithelial cells, thereby increasing or suppressing the decrease in blood IL-10 concentration, preventing or improving liver function decline, preventing or improving cholestasis, reducing total blood cholesterol or LDL cholesterol, promoting the polarization of macrophages from M1 to M2, or suppressing the decline in skin barrier function.